Provention Bio, Inc. - Common Stock (NQ:PRVB)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Provention Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles ↗

November 18, 2022

Via Benzinga

Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 18, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Tesla, Amazon, Provention Bio, Polestar, Palo Alto Networks: Musk's Court Case, Job Cuts, Earnings Pull Investor Eyeballs ↗

November 17, 2022

Major Wall Street indices closed in the red and bond yields rose on Thursday as investors and traders digested comments from a Federal Reserve official in the context of potential interest rate hikes...

Via Benzinga

Provention Bio: Q3 Earnings Insights ↗

November 03, 2022

Provention Bio (NASDAQ:PRVB) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Miniso Group, Monday.com And Other Big Gainers From Monday ↗

November 15, 2022

U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Is Provention Biosciences (PRVB) Stock Up 25% Today? ↗

November 03, 2022

Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab.

Via InvestorPlace

Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results ↗

November 03, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.

Via Benzinga

Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗

November 04, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

Via Benzinga

Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session ↗

November 03, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.

Via Benzinga

Crude Oil Down Over 1%; Lincoln National Shares Plunge ↗

November 03, 2022

U.S. stocks pared some losses midway through trading, with the Nasdaq Composite dropping around 80 points on Thursday.

Via Benzinga

US Stocks Open Lower; Nasdaq Drops 100 Points ↗

November 03, 2022

U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Thursday. The Federal Reserve, on Wednesday, raised interest rates by 75 bps.

Via Benzinga

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know ↗

November 01, 2022

October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...

Via Benzinga

These 2 Growth Stocks Have Potential Catalysts on the Way ↗

October 12, 2022

Both drugmakers have been outperforming the market -- which may continue if they earn important regulatory approvals soon.

Via The Motley Fool

Cano Health, Aehr Test Systems, Credit Suisse And Other Big Gainers From Friday ↗

October 10, 2022

U.S. stocks closed lower with the Dow Jones dropping more than 600 points on Friday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

Dow Drops Over 400 Points After US Economy Adds 263,000 Jobs During September ↗

October 07, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 400 points on Friday.

Via Benzinga

Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday ↗

October 10, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday ↗

October 07, 2022

U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session ↗

October 07, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

Dow Dips Over 300 Points; Provention Bio Shares Spike Higher ↗

October 06, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 06, 2022

Gainers

Via Benzinga

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

Why Provention Bio Shares Are Skyrocketing Today ↗

October 06, 2022

Provention Bio Inc (NASDAQ: PRVB) shares are trading higher by 20.6% to $5.97 Thursday morning after the company announced it has entered into a co-promotion agreement with Sanofi U.S. for the launch...

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

2 Stocks Jumping in Thursday's Premarket Trading ↗

October 06, 2022

Get an early start on the events of the day.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 06, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.

Via Benzinga

Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate ↗

October 06, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022 ↗

September 20, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.